Data from a proof-of-concept study show that it is safe to use focused ultrasound blood-brain barrier opening before chemotherapy in patients with newly diagnosed glioblastoma.
When compared with a matched control group, this clinical trial is the first to report a likely survival benefit.
Four expert physicians revealed exciting advances in minimally invasive treatment options, including focused ultrasound histotripsy for this challenging disease.
The event was hosted by the Foundation and the Society of Interventional Oncology.
The Small Business Innovation Research and Small Business Technology Transfer programs have helped thousands of early-stage companies develop novel ideas with support from the US government.
However, these programs officially expired in September, so start-ups cannot apply for new funds until they are renewed.
“Our results are very encouraging. Using focused ultrasound to open the blood-brain barrier and deliver chemotherapy could significantly improve patient survival, which other ongoing studies are seeking to confirm and expand.”
‒ Graeme Woodworth, MD, regarding a recent glioblastoma clinical trial